AAAAAA

   
Results: 1-17 |
Results: 17
ANTI TNF MONOCLONAL-ANTIBODY (REMICADE) IN PATIENTS WITH CROHNS-DISEASE
Authors: SCHAIBLE TF
Citation: Tf. Schaible, ANTI TNF MONOCLONAL-ANTIBODY (REMICADE) IN PATIENTS WITH CROHNS-DISEASE, European cytokine network, 9(3), 1998, pp. 576-576
CHIMERIC MONOCLONAL-ANTIBODY CA2 TO TUMOR-NECROSIS-FACTOR-ALPHA FOR CROHNS-DISEASE - REPLY
Authors: TARGAN SR SCHAIBLE TF
Citation: Sr. Targan et Tf. Schaible, CHIMERIC MONOCLONAL-ANTIBODY CA2 TO TUMOR-NECROSIS-FACTOR-ALPHA FOR CROHNS-DISEASE - REPLY, The New England journal of medicine, 338(5), 1998, pp. 334-334
ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE
Authors: DHAENS GR VANDEVENTER SJH VANHOGEZAND R CHALMERS DM BRAAKMAN TAJ SCHAIBLE TF RUTGEERTS PJ
Citation: Gr. Dhaens et al., ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 3951-3951
VALUE OF MYOCARDIAL HYPOXIA MARKERS (CREATININE KINASE AND ITS MB-FRACTION, TROPONIN-T, QT-INTERVALS) AND SERUM CREATININE FOR THE RETROSPECTIVE DIAGNOSIS OF PERINATAL ASPHYXIA
Authors: MOLLER JC THIELSEN B SCHAIBLE TF REISS I KOHL M WELP T GORTNER L
Citation: Jc. Moller et al., VALUE OF MYOCARDIAL HYPOXIA MARKERS (CREATININE KINASE AND ITS MB-FRACTION, TROPONIN-T, QT-INTERVALS) AND SERUM CREATININE FOR THE RETROSPECTIVE DIAGNOSIS OF PERINATAL ASPHYXIA, Biology of the neonate, 73(6), 1998, pp. 367-374
THERAPEUTIC EFFICACY OF MULTIPLE INTRAVENOUS INFUSIONS OF ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY COMBINED WITH LOW-DOSE WEEKLYMETHOTREXATE IN RHEUMATOID-ARTHRITIS
Authors: MAINI RN BREEDVELD FC KALDEN JR SMOLEN JS DAVIS D MACFARLANE JD ANTONI C LEEB B ELLIOTT MJ WOODY JN SCHAIBLE TF FELDMANN M
Citation: Rn. Maini et al., THERAPEUTIC EFFICACY OF MULTIPLE INTRAVENOUS INFUSIONS OF ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY COMBINED WITH LOW-DOSE WEEKLYMETHOTREXATE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1552-1563
A SHORT-TERM STUDY OF CHIMERIC MONOCLONAL-ANTIBODY CA2 TO TUMOR-NECROSIS-FACTOR-ALPHA FOR CROHNS-DISEASE
Authors: TARGAN SR HANAUER SB VANDEVENTER SJH MAYER L PRESENT DH BRAAKMAN T DEWOODY KL SCHAIBLE TF RUTGEERTS PJ
Citation: Sr. Targan et al., A SHORT-TERM STUDY OF CHIMERIC MONOCLONAL-ANTIBODY CA2 TO TUMOR-NECROSIS-FACTOR-ALPHA FOR CROHNS-DISEASE, The New England journal of medicine, 337(15), 1997, pp. 1029-1035
REPEATED INFUSIONS OF ANTI-TNF-ALPHA CHIMERIC ANTIBODY (CA2) MAINTAINREMISSION IN REFRACTORY CROHNS-DISEASE
Authors: DHAENS G RUTGEERTS P VANDEVENTER SJH PRESENT DH MAYER L HANAUER SB BRAAKMAN TAJ DEWOODY KL SCHAIBLE TF TARGAN SR
Citation: G. Dhaens et al., REPEATED INFUSIONS OF ANTI-TNF-ALPHA CHIMERIC ANTIBODY (CA2) MAINTAINREMISSION IN REFRACTORY CROHNS-DISEASE, Gut, 41, 1997, pp. 68-69
TUMOR-NECROSIS-FACTOR (TNF) MICROSATELLITE HAPLOTYPES AND PERINUCLEARANTINEUTROPHIL CYTOPLASMIC ANTIBODY (PANCA) IDENTIFY CROHNS-DISEASE (CD) PATIENTS WITH POOR CLINICAL-RESPONSES TO ANTI-TNF MONOCLONAL-ANTIBODY (CA2)
Authors: PLEVY SE TAYLOR K DEWOODY KL SCHAIBLE TF SHEALY D TARGAN SR
Citation: Se. Plevy et al., TUMOR-NECROSIS-FACTOR (TNF) MICROSATELLITE HAPLOTYPES AND PERINUCLEARANTINEUTROPHIL CYTOPLASMIC ANTIBODY (PANCA) IDENTIFY CROHNS-DISEASE (CD) PATIENTS WITH POOR CLINICAL-RESPONSES TO ANTI-TNF MONOCLONAL-ANTIBODY (CA2), Gastroenterology, 112(4), 1997, pp. 1062-1062
RETREATMENT WITH ANTI-TNF-ALPHA CHIMERIC ANTIBODY (CA2) EFFECTIVELY MAINTAINS CA2-INDUCED REMISSION IN CROHNS-DISEASE
Authors: RUTGEERTS P DHAENS G VANDEVENTER SJH PRESENT DH MAYER L HANAUER SB BRAAKMAN TAJ DEWOODY KL SCHAIBLE TF TARGAN SR
Citation: P. Rutgeerts et al., RETREATMENT WITH ANTI-TNF-ALPHA CHIMERIC ANTIBODY (CA2) EFFECTIVELY MAINTAINS CA2-INDUCED REMISSION IN CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1078-1078
REDUCED GRANULOCYTE TRAFFIC AND CHEMOTACTIC GRADIENTS IN RHEUMATOID JOINTS FOLLOWING ANTI-TNF-ALPHA THERAPY
Authors: TAYLOR PC CHAPMAN P ELLIOTT MJ SCHAIBLE TF PETERS AM FELDMANN M MAINI RN
Citation: Pc. Taylor et al., REDUCED GRANULOCYTE TRAFFIC AND CHEMOTACTIC GRADIENTS IN RHEUMATOID JOINTS FOLLOWING ANTI-TNF-ALPHA THERAPY, Arthritis and rheumatism, 40(9), 1997, pp. 297-297
LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA)
Authors: MAINI RN BREEDVELD FC KALDEN JR SMOLEN JS DAVIS D MACFARLANE JD ANTONI C LEEB B ELLIOTT MJ WOODY JN SCHAIBLE TF FELDMANN M
Citation: Rn. Maini et al., LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 571-571
BLOCKADE OF THE HUMAN PLATELET GPIIB IIIA RECEPTOR BY A MURINE MONOCLONAL-ANTIBODY FAB FRAGMENT (7E3) - POTENT DOSE-DEPENDENT INHIBITION OFPLATELET-FUNCTION/
Authors: BHATTACHARYA S JORDAN R MACHIN S SENIOR R MACKIE I SMITH CR SCHAIBLE TF WEISMAN HF LAHIRI A
Citation: S. Bhattacharya et al., BLOCKADE OF THE HUMAN PLATELET GPIIB IIIA RECEPTOR BY A MURINE MONOCLONAL-ANTIBODY FAB FRAGMENT (7E3) - POTENT DOSE-DEPENDENT INHIBITION OFPLATELET-FUNCTION/, Cardiovascular drugs and therapy, 9(5), 1995, pp. 665-675
TREATMENT OF SEVERE NONNEONATAL ARDS CHILDREN WITH SURFACTANT AND NITRIC-OXIDE IN A PRE-ECMO-SITUATION
Authors: MOLLER JC SCHAIBLE TF REISS I ARTLICH A GORTNER L
Citation: Jc. Moller et al., TREATMENT OF SEVERE NONNEONATAL ARDS CHILDREN WITH SURFACTANT AND NITRIC-OXIDE IN A PRE-ECMO-SITUATION, International journal of artificial organs, 18(10), 1995, pp. 598-602
ANTIPLATETLET MONOCLONAL-ANTIBODIES FOR THE PREVENTION OF ARTERIAL THROMBOSIS - EXPERIENCE WITH REOPRO, A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GPIIB IIIA RECEPTOR/
Authors: WEISMAN HF SCHAIBLE TF JORDAN RE CABOT CF ANDERSON KM
Citation: Hf. Weisman et al., ANTIPLATETLET MONOCLONAL-ANTIBODIES FOR THE PREVENTION OF ARTERIAL THROMBOSIS - EXPERIENCE WITH REOPRO, A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GPIIB IIIA RECEPTOR/, Biochemical Society transactions, 23(4), 1995, pp. 1051-1057
TROPONIN-T AS AN INDICATOR OF MYOCARDIAL HYPOXIA IN ASPHYXIATING NEWBORNS
Authors: MOLLER JC THIELSEN B SCHAIBLE TF TEGTMEYER FK GORTNER L
Citation: Jc. Moller et al., TROPONIN-T AS AN INDICATOR OF MYOCARDIAL HYPOXIA IN ASPHYXIATING NEWBORNS, Pediatric research, 37(4), 1995, pp. 225-225
RANDOMIZED TRIAL OF A GPIIB IIIA PLATELET RECEPTOR BLOCKER IN REFRACTORY UNSTABLE ANGINA/
Authors: SIMOONS ML DEBEER MJ VANDENBRAND MJBM VANMILTENBURG AJM HOORNTJE JCA HEYNDRICKX GR VANDERWIEKEN LR DEBONO D RUTSCH W SCHAIBLE TF WEISMAN HF KLOOTWIJK P NIJSSEN KM STIBBE J DEFEYTER PJ
Citation: Ml. Simoons et al., RANDOMIZED TRIAL OF A GPIIB IIIA PLATELET RECEPTOR BLOCKER IN REFRACTORY UNSTABLE ANGINA/, Circulation, 89(2), 1994, pp. 596-603
CARDIOVASCULAR APPLICATIONS - CURRENT STATUS OF IMMUNOSCINTIGRAPHY INTHE DETECTION OF MYOCARDIAL NECROSIS USING ANTIMYOSIN (R11D10) AND DEEP VENOUS THROMBOSIS USING ANTIFIBRIN (T2G1S)
Authors: MANSPEAKER P WEISMAN HF SCHAIBLE TF
Citation: P. Manspeaker et al., CARDIOVASCULAR APPLICATIONS - CURRENT STATUS OF IMMUNOSCINTIGRAPHY INTHE DETECTION OF MYOCARDIAL NECROSIS USING ANTIMYOSIN (R11D10) AND DEEP VENOUS THROMBOSIS USING ANTIFIBRIN (T2G1S), Seminars in nuclear medicine, 23(2), 1993, pp. 133-147
Risultati: 1-17 |